From the Sector

Reset
4 results
15.05.2024

Indorama Ventures: 1Q24 Performance

  • Sales Volume rose 3% QoQ and 2% YoY to 3.55MT
  • Adjusted EBITDA of $366M, a rise of 32% QoQ and a decline of 2% YoY
  • Operating cash flows of $184M
  • Net Operating Debt to Equity of 1.12
  • Reported EPS of THB0.17

Indorama Ventures Public Company Limited (IVL) reported an improved quarterly performance as the prolonged destocking trend showed further signs of easing. During the quarter, the company progressed its IVL 2.0 evolved strategy to enhance earnings quality and transform its business to emerge stronger from the downturn in global chemical markets.

  • Sales Volume rose 3% QoQ and 2% YoY to 3.55MT
  • Adjusted EBITDA of $366M, a rise of 32% QoQ and a decline of 2% YoY
  • Operating cash flows of $184M
  • Net Operating Debt to Equity of 1.12
  • Reported EPS of THB0.17

Indorama Ventures Public Company Limited (IVL) reported an improved quarterly performance as the prolonged destocking trend showed further signs of easing. During the quarter, the company progressed its IVL 2.0 evolved strategy to enhance earnings quality and transform its business to emerge stronger from the downturn in global chemical markets.

Indorama Ventures’ reported Adjusted EBITDA1  of $366 million in 1Q24, a 32% increase QoQ and a 2% decline YoY. Sales volume grew 3% QoQ as the widespread customer destocking that sapped demand through 2023 shows signs of a gradual recovery across all sectors, partially offset by a winter freeze in the U.S. The result was supported by lower utilities costs in Europe, Red Sea-related supply chain disruptions that benefited the company’s import parity advantages, and favorable shale gas economics that bolstered profitability in the U.S.

Indorama Ventures expects the recovery in volumes to continue through 2024, albeit at a gradual pace as destocking normalizes and the approaching summer supports demand. However, the overall landscape for the global chemical industry remains challenging due to excess capacity builds, as well due to persistent inflation and high interest rates which weigh on industry spreads and continue to impair profitability, especially across the polyester value chain. Our HVA segment ‘Indovinya’ is progressing well into the second quarter post the easing of destocking and anticipating a healthy 2024.

The company’s experienced management remains intensely focused on managing costs, optimizing competitiveness, and maintaining high liquidity. Indorama Ventures’ diverse geographical footprint is a key advantage in the current low-margin environment, allowing its businesses to maintain their strong market premium, supported by protection from trade and non-trade barriers.

In 1Q, the company made headway with its IVL 2.0 three-year plan to leverage its global leadership position and forge a new era of opportunity amid significant structural changes in chemical markets. Under the evolved strategy, which the company outlined at its annual Capital Markets Day in March, Indorama Ventures is optimizing assets, reducing debt, and focusing on generating free cash flow to deliver enhanced shareholder returns. Today, 70% of the company's revenue has deployed the SAPS/4HANA ERP and is using the infrastructure to enhance digital procurement, sales excellence, and integration of supply chains across the business. The company believes these AI tools will improve productivity and costs, as well as release working capital in line with its modernization strategy.

As part of IVL 2.0, the company is optimizing 7 sites, including the ongoing evaluation of its PTA/PET operation in the Netherlands. It has also made significant progress in its program to refinance $1.1 billion of debt within the first half of 2024 to ensure ample liquidity. Recent capital raisings include a $255 million ‘Ninja loan’, a THB 10 billion debenture, a $100M bi-lateral loan, and this week’s successful close of a $500 million syndicated loan – achieved at lower-than-average spreads compared to previous issuances.

To unlock value, Indorama Ventures is preparing its packaging and surfactants businesses for IPOs. From 1Q24, the Indovinya segment (previously named ‘Integrated Oxides and Derivatives’) is focused on developing its attractive downstream surfactants operations as a separate segment. The segment’s Intermediate Chemicals business, consisting of shale base integrated Ethylene MEG, MTBE and merchant Purified EO assets, have been moved under the Combined PET (CPET) segment where they are a natural fit.

Segment Performances
In 1Q24, CPET segment (including Intermediate Chemicals) posted Adjusted EBITDA of $249 million, a 34% gain QoQ and 4% YoY as supply chain disruptions and a consequent spike in global ocean freight rates supported high prices and margins, and as Western markets benefited from lower energy costs. The Indovinya segment reported a stable Adjusted EBITDA of $70 million, impacted by the winter freeze in the U.S and a mini turnaround at a PO/PG plant. The Fibers segment achieved a remarkable 73% increase in Adjusted EBITDA to $39 million QoQ, and 2% YoY, as destocking waned across all three business verticals and drove an 8% QoQ increase in volume.

Source:

Indorama Ventures Public Company Limited

10.03.2023

Indorama Ventures: FY22 financial performance

Indorama Ventures Public Company Limited (IVL) reported a record FY22 financial performance from the company’s global manufacturing footprint serving end-consumers’ resilient need for daily necessities. The unusually high level of customer destocking that weighed on the fourth quarter result is expected to have leveled out and business should return to normal operating conditions, with China’s reopening to further spur demand.

Indorama Ventures Public Company Limited (IVL) reported a record FY22 financial performance from the company’s global manufacturing footprint serving end-consumers’ resilient need for daily necessities. The unusually high level of customer destocking that weighed on the fourth quarter result is expected to have leveled out and business should return to normal operating conditions, with China’s reopening to further spur demand.

Full-year Core EBITDA climbed 31% YoY to $2.3 billion as revenue rose 28% to a record $18.8 billion. The company recorded strong cash flows of $2.2 billion, up 111% YoY. Indorama Ventures’ geographically diversified, integrated platform, backed by management’s agility, withstood unprecedented global events to generate earnings through the business cycle. During the year, the company continued to focus on its growth plan, successfully integrating its strategic surfactants business in Latin America and Vietnamese packaging acquisition. A dedicated senior team is working tirelessly and is committed to the company’s ‘Vision 2030’ sustainability goals including recycling technologies and introducing biomass feedstock to the company’s product portfolio. The ongoing ‘Project Olympus’ cost transformation program delivered an annual run rate of $449 million in efficiencies.

The annual result was impacted by an unusually challenging final quarter as fears of a recession and reduced transit times led to widespread destocking by customers. 4Q22 Core EBITDA declined 43% YoY to $264 million on a 1% drop in revenue to $3.9 billion. The pandemic lockdown in China also continued into the final quarter, reducing factory demand across Indorama Ventures’ portfolio and resulting in narrower margins from lower prices and higher costs. Higher energy and utility costs impacted European operations as the war in Ukraine continued into the winter.

To improve competitiveness and build resilience, Indorama Ventures rationalized underperforming assets in the Fibers business in Europe and a PTA site in Asia, resulting in a $7 million cash impairment in 4Q22 and a $253 million non-cash impact. As a result, the company looks forward to a $38 million uplift in EBITDA in 2023, reaching up to $65 million by 2025.

Source:

Indorama Ventures Public Company Limited

(c) Avgol
15.11.2021

Avgol at Hygienix™ 2021 with biotransformation technology in nonwovens

Avgol, an Indorama Ventures company and manufacturer of high-performance nonwoven fabric solutions, will be showcasing its latest work in biotransformation technology for polyolefin fibers and nonwoven fabrics at this year’s Hygienix™ event.

Nick Carter, Vice President, Nonwovens Marketing at Avgol, will be a guest speaker at the event, giving a presentation alongside Dr. DeeAnn Nelson, R&D and Innovation Manager with Avgol in North America, on ‘Biotransformation Technology in Polyolefin Fibers and Nonwoven Fabrics, Focus on Fugitive Used Articles’. “Today, the word “sustainability” does not have a unified meaning in the industries we serve,” said Nick. “Perform a regional analysis on any given customer or consumer, delve into a legislative body or advocacy group’s positioning and you will find each are likely to use the word ‘sustainable’ with varying interpretations, implementations, and implications.

The Avgol presentation, part of the Product & Process Innovation in AHPs series, will take place at 2pm on Tuesday, November 16.

Avgol, an Indorama Ventures company and manufacturer of high-performance nonwoven fabric solutions, will be showcasing its latest work in biotransformation technology for polyolefin fibers and nonwoven fabrics at this year’s Hygienix™ event.

Nick Carter, Vice President, Nonwovens Marketing at Avgol, will be a guest speaker at the event, giving a presentation alongside Dr. DeeAnn Nelson, R&D and Innovation Manager with Avgol in North America, on ‘Biotransformation Technology in Polyolefin Fibers and Nonwoven Fabrics, Focus on Fugitive Used Articles’. “Today, the word “sustainability” does not have a unified meaning in the industries we serve,” said Nick. “Perform a regional analysis on any given customer or consumer, delve into a legislative body or advocacy group’s positioning and you will find each are likely to use the word ‘sustainable’ with varying interpretations, implementations, and implications.

The Avgol presentation, part of the Product & Process Innovation in AHPs series, will take place at 2pm on Tuesday, November 16.

From their base at the tabletop event, Nick and the Avgol team will be discussing the global challenge of eliminating incineration, chemical treatment, landfill, dumping and, in particular, fugitive material pollution from non-woven products.

“Following our recent success at Index 20, we will be sharing insight to our research and development strategy with Hygienix attendees, addressing the degradation performance of our products and the path forward for the industry in terms of the use of new bio-colorants, biosurfactants and new technologies. Of course, we will also be demonstrating our latest Forward Innovative Thinking (FITTM) range of hygiene materials too, including natureFITTM”, says Nick Carter.

natureFIT™ is the newest innovation in the Avgol™ technology platform, designed to imbue nonwoven fabrics with additional qualities and benefits that anticipate the shifting demands of the consumer-led retail space. The suite of fabric solutions is focused on replacing elements of spun melt fabric design, where possible, with natural alternatives. The advanced technology affords product designers a significant reduction in polymer consumption to reduce environmental impact while simultaneously enhancing softness and conformability.

Hygienix™ runs from 15 – 18 November 2021 at the Westin Kierland Resort in Scottsdale, Arizona, USA.

More information:
Avgol Hygienix™ 2021 nonwovens
Source:

Avgol / PHD Marketing Ltd

Archroma: Whiteness Solutions for Laundry and Detergents in the U.S. (c) Archroma
20.05.2021

Archroma: Whiteness Solutions for Laundry and Detergents in the U.S.

Archroma announces a successful first year on the U.S. home care market with its whiteness solutions for laundry and detergents.

Archroma acquired in December 2019 the BASF's stilbene-based optical brightening agents (OBA) business for liquid and powder laundry detergent applications. The acquisition included the OBA technology, portfolio and manufacturing unit at Ankleshwar, India.

Since then, Archroma has mobilized its global experts, technologies and know-how, to design a holistic solutions portfolio for household, industrial & institutional cleaning (HI&I) aimed to support detergent manufacturers.

The portfolio now includes solutions for whiteness, coloration, stain removal, fabric softening, as well as sequestering agents and surfactants, which can be used in applications such as multipurpose cleaning powders, detergent powders, dish wash tablets and liquids, laundry liquids and fabric softeners, and hard surface cleaners.

Archroma announces a successful first year on the U.S. home care market with its whiteness solutions for laundry and detergents.

Archroma acquired in December 2019 the BASF's stilbene-based optical brightening agents (OBA) business for liquid and powder laundry detergent applications. The acquisition included the OBA technology, portfolio and manufacturing unit at Ankleshwar, India.

Since then, Archroma has mobilized its global experts, technologies and know-how, to design a holistic solutions portfolio for household, industrial & institutional cleaning (HI&I) aimed to support detergent manufacturers.

The portfolio now includes solutions for whiteness, coloration, stain removal, fabric softening, as well as sequestering agents and surfactants, which can be used in applications such as multipurpose cleaning powders, detergent powders, dish wash tablets and liquids, laundry liquids and fabric softeners, and hard surface cleaners.

Archroma used its experience working with manufacturers and brands in the textile industry to enter the US detergent markets for the very first time, and has been able to gain a significant position with most key laundry detergent manufacturers with its solutions for whiteness.

In particular, the company reports special interest from U.S. detergent brands and manufacturers for its Leucophor® 5BMGX, as this optical brightener allows them to achieve high levels of whiteness with a blueish undertone. The product is also highly soluble in water and stable in oxidative environment.

Source:

EMG